Ars Pharmaceuticals Inc (SPRY)
Cost of Revenue
$12.85M
Quarterly · Period ending: · USD
SPRY Cost of Revenue
Latest reported$12.85Mperiod ending
Latest reported$12.85Mperiod ending
SPRY Quarterly Cost of Revenue ($395.00K → $12.85M)
Quarterly cost of revenue
High-resolution chart · PNG
SPRY cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 12,846,000 | |
| 6,286,000 | |
| 3,202,000 | |
| 8,191,000 | |
| 4,984,000 | |
| 4,046,000 | |
| 3,892,000 | |
| 112,000 | |
| 6,896,000 | |
| 5,234,000 | |
| 3,404,000 | |
| 3,002,000 | |
| 7,208,000 | |
| 6,452,000 | |
| 3,554,000 | |
| 3,793,000 | |
| 4,350,000 | |
| 5,423,000 | |
| 3,914,000 | |
| 5,122,000 | |
| 5,618,500 | |
| 5,618,500 | |
| 465,000 | |
| 403,000 | |
| 401,000 | |
| 395,000 |